Skip to main content
Top
Published in: Cancer Immunology, Immunotherapy 12/2015

01-12-2015 | Original Article

Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients

Authors: Luciane Zabijak, Christophe Attencourt, Caroline Guignant, Denis Chatelain, Paulo Marcelo, Jean-Pierre Marolleau, Emmanuel Treiner

Published in: Cancer Immunology, Immunotherapy | Issue 12/2015

Login to get access

Abstract

The infiltration of tumors by lymphocytes is a prognosis factor in colorectal cancer (CRC). The magnitude and quality of this infiltration have emerged as important component of the clinical outcome in these patients. Specifically, markers associated with functional cell-mediated immunity, i.e., a Th1 immune response, are independent markers of better prognosis, whereas Th17-associated components are deleterious and correlate with poorer survival. Mucosal-associated invariant T (MAIT) cells are a recently described T cell subset with tissue-homing properties. They display a restricted TCR repertoire specific for widely conserved microbial ligands, and display anti-bacterial properties upon release of Th1-like, Th17-like, and/or cytotoxic granules. MAIT-cell-specific transcripts have been found in kidney and brain cancer, but have not been studies in other sites. In this study, we retrospectively analyzed by confocal microscopy the presence of MAIT cells within colorectal tumors as compared with paired healthy tissues. We observed a significant although variable increase, both in density and in proportion of overall tumor-infiltrating T lymphocytes inside the tumors. Importantly, survival curves as well as multivariate analysis showed that patients displaying a higher recruitment of MAIT cells in their tumor, as compared with the neighboring healthy tissue, showed a less favorable clinical outcome. This study suggests that including MAIT-cell-specific markers or transcripts in the analysis of tumor-infiltrating lymphocytes could be a benefit to the diagnosis and follow-up of CRC patients.
Literature
1.
go back to reference Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331(6024):1565–1570CrossRefPubMed Schreiber RD, Old LJ, Smyth MJ (2011) Cancer immunoediting: integrating immunity’s roles in cancer suppression and promotion. Science 331(6024):1565–1570CrossRefPubMed
2.
go back to reference Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12(4):298–306CrossRefPubMed Fridman WH, Pages F, Sautes-Fridman C, Galon J (2012) The immune contexture in human tumours: impact on clinical outcome. Nat Rev Cancer 12(4):298–306CrossRefPubMed
3.
go back to reference Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654–2666CrossRefPubMed Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R et al (2005) Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med 353(25):2654–2666CrossRefPubMed
4.
go back to reference Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, Krambeck AE et al (2007) Tumor-infiltrating Foxp3−CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 13(7):2075–2081CrossRefPubMed Siddiqui SA, Frigola X, Bonne-Annee S, Mercader M, Kuntz SM, Krambeck AE et al (2007) Tumor-infiltrating Foxp3−CD4+CD25+ T cells predict poor survival in renal cell carcinoma. Clin Cancer Res 13(7):2075–2081CrossRefPubMed
5.
go back to reference Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC (2001) Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol 167(5):2972–2978CrossRefPubMed Sheu BC, Lin RH, Lien HC, Ho HN, Hsu SM, Huang SC (2001) Predominant Th2/Tc2 polarity of tumor-infiltrating lymphocytes in human cervical cancer. J Immunol 167(5):2972–2978CrossRefPubMed
6.
go back to reference Roussel E, Gingras MC, Grimm EA, Bruner JM, Moser RP (1996) Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas. Clin Exp Immunol 105(2):344–352PubMedCentralCrossRefPubMed Roussel E, Gingras MC, Grimm EA, Bruner JM, Moser RP (1996) Predominance of a type 2 intratumoural immune response in fresh tumour-infiltrating lymphocytes from human gliomas. Clin Exp Immunol 105(2):344–352PubMedCentralCrossRefPubMed
7.
go back to reference Li X, Ye DF, Xie X, Chen HZ, Lu WG (2005) Proportion of CD4+CD25+ regulatory T cell is increased in the patients with ovarian carcinoma. Cancer Invest 23(5):399–403PubMed Li X, Ye DF, Xie X, Chen HZ, Lu WG (2005) Proportion of CD4+CD25+ regulatory T cell is increased in the patients with ovarian carcinoma. Cancer Invest 23(5):399–403PubMed
8.
go back to reference Kharkevitch DD, Seito D, Balch GC, Maeda T, Balch CM, Itoh K (1994) Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int J Cancer 58(3):317–323CrossRefPubMed Kharkevitch DD, Seito D, Balch GC, Maeda T, Balch CM, Itoh K (1994) Characterization of autologous tumor-specific T-helper 2 cells in tumor-infiltrating lymphocytes from a patient with metastatic melanoma. Int J Cancer 58(3):317–323CrossRefPubMed
9.
go back to reference Asselin-Paturel C, Echchakir H, Carayol G, Gay F, Opolon P, Grunenwald D et al (1998) Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int J Cancer 77(1):7–12CrossRefPubMed Asselin-Paturel C, Echchakir H, Carayol G, Gay F, Opolon P, Grunenwald D et al (1998) Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients. Int J Cancer 77(1):7–12CrossRefPubMed
10.
go back to reference Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G et al (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71(4):1263–1271CrossRefPubMed Tosolini M, Kirilovsky A, Mlecnik B, Fredriksen T, Mauger S, Bindea G et al (2011) Clinical impact of different classes of infiltrating T cytotoxic and helper cells (Th1, th2, treg, th17) in patients with colorectal cancer. Cancer Res 71(4):1263–1271CrossRefPubMed
11.
go back to reference Lv L, Pan K, Li XD, She KL, Zhao JJ, Wang W et al (2011) The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS ONE 6(3):e18219PubMedCentralCrossRefPubMed Lv L, Pan K, Li XD, She KL, Zhao JJ, Wang W et al (2011) The accumulation and prognosis value of tumor infiltrating IL-17 producing cells in esophageal squamous cell carcinoma. PLoS ONE 6(3):e18219PubMedCentralCrossRefPubMed
12.
go back to reference Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S et al (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114(6):1141–1149PubMedCentralCrossRefPubMed Kryczek I, Banerjee M, Cheng P, Vatan L, Szeliga W, Wei S et al (2009) Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments. Blood 114(6):1141–1149PubMedCentralCrossRefPubMed
13.
go back to reference Chen X, Wan J, Liu J, Xie W, Diao X, Xu J et al (2010) Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer 69(3):348–354CrossRefPubMed Chen X, Wan J, Liu J, Xie W, Diao X, Xu J et al (2010) Increased IL-17-producing cells correlate with poor survival and lymphangiogenesis in NSCLC patients. Lung Cancer 69(3):348–354CrossRefPubMed
14.
go back to reference Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960–1964CrossRefPubMed Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pages C et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313(5795):1960–1964CrossRefPubMed
16.
go back to reference Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M et al (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11(8):701–708CrossRefPubMed Le Bourhis L, Martin E, Peguillet I, Guihot A, Froux N, Core M et al (2010) Antimicrobial activity of mucosal-associated invariant T cells. Nat Immunol 11(8):701–708CrossRefPubMed
17.
go back to reference Gold MC, Lewinsohn DM (2013) Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat Rev Microbiol 11(1):14–19CrossRefPubMed Gold MC, Lewinsohn DM (2013) Co-dependents: MR1-restricted MAIT cells and their antimicrobial function. Nat Rev Microbiol 11(1):14–19CrossRefPubMed
18.
go back to reference Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D et al (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117(4):1250–1259CrossRefPubMed Dusseaux M, Martin E, Serriari N, Peguillet I, Premel V, Louis D et al (2011) Human MAIT cells are xenobiotic-resistant, tissue-targeted, CD161hi IL-17-secreting T cells. Blood 117(4):1250–1259CrossRefPubMed
19.
go back to reference Leung DT, Bhuiyan TR, Nishat NS, Hoq MR, Aktar A, Rahman MA et al (2014) Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl Trop Dis 8(8):e3076PubMedCentralCrossRefPubMed Leung DT, Bhuiyan TR, Nishat NS, Hoq MR, Aktar A, Rahman MA et al (2014) Circulating mucosal associated invariant T cells are activated in Vibrio cholerae O1 infection and associated with lipopolysaccharide antibody responses. PLoS Negl Trop Dis 8(8):e3076PubMedCentralCrossRefPubMed
20.
go back to reference Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F et al (2014) Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med 40(2):192–201CrossRefPubMed Grimaldi D, Le Bourhis L, Sauneuf B, Dechartres A, Rousseau C, Ouaaz F et al (2014) Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections. Intensive Care Med 40(2):192–201CrossRefPubMed
21.
go back to reference Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J et al (2010) Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 8(6):e1000407PubMedCentralCrossRefPubMed Gold MC, Cerri S, Smyk-Pearson S, Cansler ME, Vogt TM, Delepine J et al (2010) Human mucosal associated invariant T cells detect bacterially infected cells. PLoS Biol 8(6):e1000407PubMedCentralCrossRefPubMed
22.
go back to reference Willing A, Leach OA, Ufer F, Attfield KE, Steinbach K, Kursawe N et al (2014) CD8(+) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol 44(10):3119–3128CrossRefPubMed Willing A, Leach OA, Ufer F, Attfield KE, Steinbach K, Kursawe N et al (2014) CD8(+) MAIT cells infiltrate into the CNS and alterations in their blood frequencies correlate with IL-18 serum levels in multiple sclerosis. Eur J Immunol 44(10):3119–3128CrossRefPubMed
23.
go back to reference Teunissen MB, Yeremenko NG, Baeten DL, Chielie S, Spuls PI, de Rie MA et al (2014) The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J Invest Dermatol 134(12):2898–2907CrossRefPubMed Teunissen MB, Yeremenko NG, Baeten DL, Chielie S, Spuls PI, de Rie MA et al (2014) The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells. J Invest Dermatol 134(12):2898–2907CrossRefPubMed
24.
go back to reference Serriari NE, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P et al (2014) Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol 176(2):266–274PubMedCentralCrossRefPubMed Serriari NE, Eoche M, Lamotte L, Lion J, Fumery M, Marcelo P et al (2014) Innate mucosal-associated invariant T (MAIT) cells are activated in inflammatory bowel diseases. Clin Exp Immunol 176(2):266–274PubMedCentralCrossRefPubMed
25.
go back to reference Miyazaki Y, Miyake S, Chiba A, Lantz O, Yamamura T (2011) Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol 23(9):529–535CrossRefPubMed Miyazaki Y, Miyake S, Chiba A, Lantz O, Yamamura T (2011) Mucosal-associated invariant T cells regulate Th1 response in multiple sclerosis. Int Immunol 23(9):529–535CrossRefPubMed
26.
go back to reference Peterfalvi A, Gomori E, Magyarlaki T, Pal J, Banati M, Javorhazy A et al (2008) Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells. Int Immunol 20(12):1517–1525CrossRefPubMed Peterfalvi A, Gomori E, Magyarlaki T, Pal J, Banati M, Javorhazy A et al (2008) Invariant Valpha7.2-Jalpha33 TCR is expressed in human kidney and brain tumors indicating infiltration by mucosal-associated invariant T (MAIT) cells. Int Immunol 20(12):1517–1525CrossRefPubMed
27.
go back to reference Greathead L, Metcalf R, Gazzard B, Gotch F, Steel A, Kelleher P (2014) CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation. AIDS 28(11):1690–1692CrossRefPubMed Greathead L, Metcalf R, Gazzard B, Gotch F, Steel A, Kelleher P (2014) CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation. AIDS 28(11):1690–1692CrossRefPubMed
28.
go back to reference Novak J, Dobrovolny J, Novakova L, Kozak T (2014) The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age. Scand J Immunol 80(4):271–275CrossRefPubMed Novak J, Dobrovolny J, Novakova L, Kozak T (2014) The decrease in number and change in phenotype of mucosal-associated invariant T cells in the elderly and differences in men and women of reproductive age. Scand J Immunol 80(4):271–275CrossRefPubMed
29.
go back to reference Wang K, Kim MK, Di Caro G, Wong J, Shalapour S, Wan J et al (2014) Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity 41(6):1052–1063CrossRefPubMed Wang K, Kim MK, Di Caro G, Wong J, Shalapour S, Wan J et al (2014) Interleukin-17 receptor a signaling in transformed enterocytes promotes early colorectal tumorigenesis. Immunity 41(6):1052–1063CrossRefPubMed
30.
go back to reference Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D et al (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491(7423):254–258PubMedCentralPubMed Grivennikov SI, Wang K, Mucida D, Stewart CA, Schnabl B, Jauch D et al (2012) Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth. Nature 491(7423):254–258PubMedCentralPubMed
31.
go back to reference Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI (2005) Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100(12):2724–2729CrossRefPubMed Jess T, Gamborg M, Matzen P, Munkholm P, Sorensen TI (2005) Increased risk of intestinal cancer in Crohn’s disease: a meta-analysis of population-based cohort studies. Am J Gastroenterol 100(12):2724–2729CrossRefPubMed
Metadata
Title
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patients
Authors
Luciane Zabijak
Christophe Attencourt
Caroline Guignant
Denis Chatelain
Paulo Marcelo
Jean-Pierre Marolleau
Emmanuel Treiner
Publication date
01-12-2015
Publisher
Springer Berlin Heidelberg
Published in
Cancer Immunology, Immunotherapy / Issue 12/2015
Print ISSN: 0340-7004
Electronic ISSN: 1432-0851
DOI
https://doi.org/10.1007/s00262-015-1764-7

Other articles of this Issue 12/2015

Cancer Immunology, Immunotherapy 12/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine